Clinical Trial Update: Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina [Phase 3]

View source ↗

Summary

Phase 3 trial of cilostazol for vasospastic angina has completed; the provided information does not include efficacy or safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasospastic Angina

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Vasospastic Angina | Phase 3 | Status: COMPLETED